DK0533294T3 - Kyllingeanæmiagensvaccine. - Google Patents

Kyllingeanæmiagensvaccine.

Info

Publication number
DK0533294T3
DK0533294T3 DK92202864.2T DK92202864T DK0533294T3 DK 0533294 T3 DK0533294 T3 DK 0533294T3 DK 92202864 T DK92202864 T DK 92202864T DK 0533294 T3 DK0533294 T3 DK 0533294T3
Authority
DK
Denmark
Prior art keywords
vaccine
chicken anemia
chicken
anemia vaccine
evoking
Prior art date
Application number
DK92202864.2T
Other languages
Danish (da)
English (en)
Inventor
Carla Christina Schrier
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0533294T3 publication Critical patent/DK0533294T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92202864.2T 1991-09-20 1992-09-18 Kyllingeanæmiagensvaccine. DK0533294T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91202452 1991-09-20

Publications (1)

Publication Number Publication Date
DK0533294T3 true DK0533294T3 (da) 1997-07-07

Family

ID=8207891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92202864.2T DK0533294T3 (da) 1991-09-20 1992-09-18 Kyllingeanæmiagensvaccine.

Country Status (17)

Country Link
US (1) US5728569A (de)
EP (1) EP0533294B1 (de)
JP (2) JP3945830B2 (de)
KR (1) KR100221710B1 (de)
CN (1) CN1050302C (de)
AT (1) ATE147632T1 (de)
AU (1) AU659490B2 (de)
CA (1) CA2078605C (de)
DE (1) DE69216732T2 (de)
DK (1) DK0533294T3 (de)
ES (1) ES2099200T3 (de)
GR (1) GR3022755T3 (de)
HU (2) HU217214B (de)
MX (1) MX9205336A (de)
NZ (1) NZ244361A (de)
TW (1) TW340873B (de)
ZA (1) ZA927014B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071520A (en) * 1990-09-12 2000-06-06 Leadd Bv Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
US5981502A (en) * 1990-09-12 1999-11-09 Leadd B.V. Methods and compositions for inducing apoptosis in tumor cells
US6217870B1 (en) 1990-09-12 2001-04-17 Leadd, Bv Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US6162461A (en) * 1990-09-12 2000-12-19 Leadd B.V. Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
AU4486096A (en) 1995-01-06 1996-07-24 Akzo Nobel N.V. Chicken anaemia agent broiler vaccine
ZA978434B (en) * 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.
US6159472A (en) * 1998-11-16 2000-12-12 Akzo Nobel N.V. Intradermal Avian immunization with inactivated vaccines
JP2001275664A (ja) * 2000-02-29 2001-10-09 Akzo Nobel Nv 低い病原性のニワトリ貧血ウイルス
US6593134B1 (en) 2000-03-10 2003-07-15 Cornell Research Foundation, Inc. Method of propagating chicken infectious anemia virus
US20050169939A1 (en) * 2001-09-05 2005-08-04 Leonard Joan D. Chicken anemia virus vaccine from cell line
BRPI0508490A (pt) * 2004-03-05 2008-08-12 Biomune Company vacina de vìrus da anemia da galinha a partir de linhagem celular
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
MX2017014414A (es) 2015-05-14 2018-03-16 Merial Inc Metodo para la produccion de circovirus porcino y vacunas pcv2.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3616262A (en) * 1967-06-09 1971-10-26 Merck & Co Inc Apparatus and method for propagating viruses i in the extra-embryonic fluids of eggs
BE853923A (fr) * 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine

Also Published As

Publication number Publication date
ATE147632T1 (de) 1997-02-15
EP0533294A1 (de) 1993-03-24
DE69216732D1 (de) 1997-02-27
US5728569A (en) 1998-03-17
GR3022755T3 (en) 1997-06-30
KR930006150A (ko) 1993-04-20
TW340873B (en) 1998-09-21
ES2099200T3 (es) 1997-05-16
CA2078605A1 (en) 1993-03-21
NZ244361A (en) 1995-06-27
MX9205336A (es) 1993-07-01
HU211896A9 (en) 1995-12-28
ZA927014B (en) 1993-03-19
CN1073879A (zh) 1993-07-07
AU2521792A (en) 1993-03-25
DE69216732T2 (de) 1997-06-12
CN1050302C (zh) 2000-03-15
JP4148980B2 (ja) 2008-09-10
CA2078605C (en) 2003-06-17
EP0533294B1 (de) 1997-01-15
JP3945830B2 (ja) 2007-07-18
AU659490B2 (en) 1995-05-18
KR100221710B1 (ko) 1999-10-01
JPH05260962A (ja) 1993-10-12
JP2007125039A (ja) 2007-05-24
HU9202976D0 (en) 1992-11-30
HUT65367A (en) 1994-05-02
HU217214B (hu) 1999-12-28

Similar Documents

Publication Publication Date Title
DK0533294T3 (da) Kyllingeanæmiagensvaccine.
DK0625053T3 (da) Urease-baseret vaccine mod Helicobacter-infektion
DK0650733T3 (da) Levende svækket in ovo-vaccine
NL300184I1 (nl) Acellulair vaccin.
IL130075A0 (en) A vaccine for eliciting an immune response to an antigen in an animal
DK0639640T3 (da) Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91
DK0838222T3 (da) Vaccinesammensætninger, der omfatter inaktiverede immunogener og levende kyllingeanæmi-virus (CAV)
DK47083D0 (da) Fremgangsmade til fremstilling af levende eller inaktiverede vacciner mod infektioes bronkitis
DE68920345D1 (de) Lebendes Kombinationsvakzin.
ATE310078T1 (de) Hühner-anäemie-virus mit geringer pathogenität
DK0545951T3 (da) HRSV-vaccine
DK336186A (da) Vaccine mod smitsom bronchitis hos daggamle kyllinger
DK569985D0 (da) Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus
NZ243251A (en) Vaccine against marek's disease virus in poultry
ATE177010T1 (de) Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie